Recently, a preoperative systemic inflammatory response has been reported to be a prognostic factor in patients with colorectal cancer (CRC). However, the prognostic significance of a systemic inflammatory response in the early stage after surgery in patients with CRC is unknown. The aim of this retrospective study was to evaluate the prognostic significance of a postoperative systemic inflammatory response in patients with CRC.
Methods
Two hundred and fifty-four patients who underwent potentially curative surgery for stage II/III CRC were enrolled in this study. Univariate and multivariate analyses were performed to evaluate the relationship between the prognosis and clinicopathological factors, including the neutrophil-to-lymphocyte ratio (NLR) and Glasgow Prognostic Score (GPS), which were measured within two weeks before operation and at the first visit after leaving the hospital.
Results
The overall survival rates were significantly worse in the high preoperative NLR/preoperative GPS/postoperative NLR group. A multivariate analysis indicated that only preoperative GPS, postoperative NLR, and the number of lymph node metastases were independent prognostic factors for a poor survival.
Conclusions
The postoperative NLR is an independent prognostic factor in patients with CRC who underwent potentially curative surgery.
Hinweise
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MS and KM designed the study, performed the statistical analysis, and drafted the manuscript. HN, HO, YI, TI, and KS collected the clinical data. KH designed the study and critically reviewed the manuscript. All authors read and approved the final manuscript.
Abkürzungen
CA19-9
carbohydrate antigen 19–9
CEA
carcinoembryonic antigen
CapeOX
capecitabine plus oxaliplatin
CRC
colorectal cancer
CRP
C-reactive protein
FOLFOX
5-fluorouracil/leucovorin plus oxaliplatin
GPS
Glasgow prognostic score
NLR
neutrophil-to-lymphocyte ratio
ROC
receiver-operating characteristic
Background
Colorectal cancer (CRC) is the third leading cause of cancer death worldwide [1]. Although the surgical procedures and chemotherapy have improved, a large number of patients relapse after curative resection, and the mortality from colorectal cancer is still high. Therefore, it is necessary to identify the patients with a high possibility of recurrence, and various biomarkers associated with poor survival have been examined.
Recently, the systemic inflammatory response has been recognized to correlate with the progression of the tumor and the prognosis of various types of cancer, including CRC. The markers of the systemic inflammatory response, such as the neutrophil-to-lymphocyte ratio (NLR) [2‐4], serum C-reactive protein (CRP) level [5, 6], and Glasgow prognostic score (GPS) [4, 7, 8] have been reported to be associated with the prognosis in patients with CRC. However, most of these reports investigated the preoperative status, and there have been no reports on the relationship between the systemic inflammatory response in the early stage after surgery and the prognosis after potentially curative resection of CRC. The aim of this retrospective study was to evaluate the prognostic significance of the postoperative systemic inflammatory response in patients with CRC.
Anzeige
Methods
We retrospectively reviewed a database of 254 patients who underwent potentially curative surgery for stage II/III CRC at the Department of Surgical Oncology of Osaka City University between 2006 and 2011. Curative surgery was defined as the absence of any gross residual tumor tissue in the surgical bed, with a surgical resection margin that was pathologically negative for tumor invasion. Patients who received preoperative therapy or who had either bowel obstruction or perforation due to their primary tumor were excluded from the analysis.
The patient population consisted of 139 males and 115 females, with a median age of 60 years (range, 26 to 86). One hundred and thirty-one patients had tumors located in the colon, and 123 had tumors located in the rectum. One hundred and seventy-eight patients received monotherapy using an oral pro-drug based on 5-FU, such as capecitabine, while 30 patients received combination therapy with 5-FU and oxaliplatin, such as 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) or capecitabine plus oxaliplatin (CapeOX) (Table 1).
Table 1
The patient characteristics
Gender
Male
139
Female
115
Age (years)
Median (range)
66 (26–86)
Location of primary tumor
Colon
131
Rectum
123
Tumor depth
T1-3
176
T4
77
Histological type
Well, moderately
234
Poorly, mucinous
19
Lymphatic involvement
Negative
47
Positive
184
Venous involvement
Negative
170
Positive
68
Number of lymph node metastases
0
85
1–3
116
≥4
53
Stage
II
85
III
169
Regimen of chemotherapy
Oral 5-FU monotherapy
178
CapeOX
19
FOLFOX
11
None
46
Median value of indicators of the preoperative systemic inflammatory response (range)
NLR
2.26 (0.87–10.24)
CRP (mg/dl)
0.11 (0.01–13.99)
Preoperative serum albumin level (g/dl)
Median (range)
4.1 (2.6–4.8)
Median value of indicators of the postoperative systemic inflammatory response (range)
NLR
1.82 (0.18–10.11)
CRP (mg/dl)
0.09 (0.01–17.09)
Postoperative serum albumin level (g/dl)
Median (range)
4.0 (3.0–4.7)
The number of days from operation until the first visit after leaving the hospital
Median (interquartile range)
29 (23–36)
5-FU 5-fluorouracil, CapeOX capecitabine plus oxaliplatin, FOLFOX 5-fluorouracil/leucovorin plus oxaliplatin, NLR neutrophil-to-lymphocyte ratio, CRP C-reactive protein
The postoperative systemic inflammatory response was measured at the first visit after leaving the hospital. The date of the first visit was set to occur two to three weeks after the patient left the hospital. The median (interquartile range) period from the operation until the first visit after leaving the hospital was 29 (23–36) days. The NLR was calculated from a blood sample by dividing the absolute neutrophil count by the absolute lymphocyte count. According to the receiver-operating characteristic (ROC) curve, we set 2.5 as the cut-off value for the preoperative NLR (the sensitivity was 51.9 % and the specificity was 64.2 %) (Fig. 1a) and classified the patients into high preoperative NLR (≥2.5) and low preoperative NLR (<2.5) groups. Moreover, according to the ROC curve, we also set 3.0 as the cut-off value for the postoperative NLR (the sensitivity was 35.7 % and the specificity was 87.3 %) (Fig. 1b) and classified the patients into high postoperative NLR (≥3.0) and low-postoperative NLR (<3.0) groups.
×
We defined the GPS according to the previous reports as follows [9]: the GPS consists of the combination of an elevated CRP (≥1 mg/dl) and hypoalbuminemia (<3.5 g/dl). Patients with both abnormalities were allocated a GPS of 2. Patients with only one of these abnormalities were allocated a GPS of 1. Patients with normal values for both were allocated a GPS of 0. The patients with a GPS of 1 or 2 were classified into the high GPS group, and those with a GPS of 0 were classified into the low-GPS group.
Anzeige
We then examined the correlations between the clinicopathological parameters, including the postoperative NLR/GPS and the prognosis for survival. All patients were followed up regularly with physical and blood examinations and mandatory screening using colonoscopy and computed tomography until May 2014 or death. Among the total 254 patients, 86 developed recurrent disease and 42 patients died.
The resected specimens were pathologically classified according to the seventh edition of the Union for International Cancer Control TNM classification of malignant tumors [10]. The significance of the correlations between the systemic inflammatory response and the clinicopathological characteristics was analyzed by the χ2 test, Fisher’s exact test, and t-test. The duration of survival was calculated according to the Kaplan-Meier method. Differences in the survival curves were assessed with the log-rank test. A multivariate analysis was performed according to the Cox proportional hazards model. All statistical analyses were conducted using the SPSS software package for Windows (SPSS Japan, Tokyo, Japan). Statistical significance was set at a value of p <0.05.
Results
The preoperative/postoperative indicators of a systemic inflammatory response are shown in Table 1. The distribution of patients based on the indicators of a systemic inflammatory response is shown in Table 2.
Table 2
The distribution of patients based on the indicators of the postoperative systemic inflammatory response
As for the preoperative inflammatory status, an assessment of the prognosis showed that the overall survival rates were significantly worse in the high preoperative NLR/GPS group (NLR, p = 0.0388; GPS, p = 0.0028) (Fig. 2). Moreover, as for the postoperative inflammatory status, the overall survival rates were significantly worse in the high postoperative NLR group (p = 0.0006), while there was no relationship between the postoperative GPS and mortality (Fig. 3). The postoperative NLR had a significant relationship with the amount of blood loss during the operation and the length of the operation and tended to correlated with gender, while there was no relationship between the postoperative NLR and other factors including preoperative NLR (Table 3). The postoperative GPS had a significant relationship with lymphatic involvement, the number of lymph node metastasis, the preoperative CA19-9 level, and the preoperative GPS (Table 3). With regard to the relationships between the postoperative systemic inflammatory response and the sub-classification of the postoperative infectious complications, neither NLR nor GPS showed a significant relationship with the sub-classification of the postoperative infectious complications (Table 4).
Table 3
The correlation between the postoperative systemic inflammatory response and the clinicopathological factors
The correlations between the overall survival and various clinicopathological factors are shown in Table 5. According to a univariate analysis, the overall survival had significant relationships with the postoperative NLR, the preoperative NLR, the preoperative GPS, age, the tumor depth, histological type, venous involvement, and the number of lymph node metastases. However, a multivariate analysis indicated that only the preoperative GPS, the postoperative NLR, and the number of lymph node metastases were independent risk factors for mortality.
Table 5
The correlations between the overall survival and various clinicopathological factors
We categorized the patients into four groups according to the combination of their preoperative and postoperative NLR. Patients with the low preoperative and postoperative NLR categorized into group A. Patients with the low preoperative NLR and the high postoperative NLR were categorized into group B. Patients with the high preoperative NLR and the low-postoperative NLR were categorized into group C. Patients with the high preoperative and postoperative NLR categorized into group D. The patients in group A exhibited a better prognosis compared to the other groups (AvsB, p = 0.0124; AvsC, p = 0.0202; AvsD, p = 0.0031), while there was no significant difference between groups B, C, and D with regard to survival (Fig. 4).
×
Discussion
In this study, we investigated the correlations between the high postoperative NLR and poor survival in patients with colorectal cancer who underwent potentially curative surgery. When considering the prognosis of patients with malignant tumors, the TNM-classification criteria [10], which are factors related to the tumor and accurately reflect the prognosis, have been widely used. Recently, the prognostic significance of the factors related to the host based on the systemic inflammatory response, such as the NLR, CRP, and GPS in patients with CRC, has been reported [2‐8]. However, most of the previous reports focused on the preoperative status, and there have been only a few reports which focused on the prognostic significance of the postoperative systemic inflammatory response. To the best of our knowledge, this is the first study assessing the prognostic significance of the systemic inflammatory response in the early stage after surgery.
Neutrophils play a key role in tumor progression, producing a number of ligands that induce tumor cell proliferation and invasion, and promoting tumor vascularization by releasing proangiogenic chemokines and other factors [11, 12]. As the main cause of recurrence after potentially curative operation may be the growth of micrometastases which had been established prior to resection [13], and because the continuous systemic inflammatory response creates a favorable environment for micrometastatic growth, a persistently elevated level of neutrophils after surgery is considered to correlate with the development of recurrence. In contrast, lymphocytes, which play an important role in anti-tumor immunity, are a factor related to the immune system of the host [14]. The absolute lymphocyte count is assumed to reflect the degree of responsiveness of a cancer patient’s whole immune system [15]. Therefore, a decrease of lymphocytes is considered to correlate with recurrence. Taken together, a persistently high NLR after surgery means the continuation of an environment that is favorable for recurrence. Thus, the postoperative status, as well as the preoperative status of the host, is important when considering the prognosis.
Anzeige
The mechanism of the persistent activation of the systemic inflammatory response after surgery remains unclear. In this study, a high postoperative NLR was significantly correlated with the amount of blood loss during the operation and the length of the operation. These results suggested that a high postoperative NLR might be associated with higher surgical stress. However, we could not conclude that the main cause of the persistent elevation of the systemic inflammatory response after the operation was surgical stress itself, because other than the parameters of blood loss during the operation and the length of the operation, there are no useful markers for evaluating the degree of surgical stress, and the markers on their own were not sufficient to perform an evaluation. On the other hand, the postoperative NLR had no association with the factors related to the tumor, although the preoperative NLR was previously reported to correlate with several factors related to the tumor [2]. Moreover, the postoperative NLR had no relationship with the presence of postoperative infectious complications, even when performing the additional analyses regarding the degree and type of postoperative infectious complications. There were some patients with normal inflammatory marker levels at the first visit after leaving the hospital who developed postoperative infectious complications, while some patients with high postoperative systemic inflammatory marker levels were discharged without postoperative complications. The postoperative infectious complications may not be the main cause of the high postoperative systemic inflammatory response at the first visit after leaving the hospital. Aside from surgical stress and the postoperative infectious complications, the response of the host to the micrometastatic lesion has been reported to cause a persistently high postoperative systemic inflammatory response [16]. However, it is questionable whether the response to the micrometastatic lesion and the response to the primary tumor are equivalent.
Our results were in line with a study by Guthrie et al., which reported that the persistent elevation of the systemic inflammatory response after surgery was correlated with poor survival [16]. However, we obtained different results in relation to the superiority of the postoperative inflammatory markers. We found postoperative NLR to be superior to the postoperative GPS, while Guthrie et al. reported the opposite [16]. Moreover, the timing of the valuation of the postoperative inflammatory response differed between this study and the previous report. In this study the postoperative inflammatory response was evaluated in the early stage after operation (approximately 1–2 months after surgery, when we decided the regimen of adjuvant chemotherapy), while in the previous report, the inflammatory response was evaluated at 3–6 months after surgery [16].
There are some limitations associated with this study. First, we evaluated a relatively small number of patients. Second, the criteria for the first visit after leaving the hospital were not uniform because this study was a retrospective study. Third, the appropriate timing for the evaluation of the postoperative systemic inflammatory response to predict the survival was unknown. Fourth, the mechanism of the persistent elevation of the postoperative inflammatory response remains unclear. A large, prospective study should therefore be performed to confirm our findings.
Conclusions
In this study, the postoperative NLR was demonstrated to correlate with a poor survival as well as the preoperative NLR and the postoperative NLR were investigated to be an independent prognostic factor for poor survival. Therefore, not only the preoperative status of the host, but also the postoperative status of the host, is important when considering the prognosis.
Anzeige
Acknowledgements
The funding agency had no role in the study design, in the collection, analysis, and interpretation of the data, in the writing of the report, and in the decision to submit the article for publication. We thank Brian Quinn who provided medical-writing service on behalf of JMC Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MS and KM designed the study, performed the statistical analysis, and drafted the manuscript. HN, HO, YI, TI, and KS collected the clinical data. KH designed the study and critically reviewed the manuscript. All authors read and approved the final manuscript.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.